Image source: The Motley Fool.
Bio-Rad Laboratories Inc (NYSE: BIO)
Q3 2020 Earnings Call
Oct 29, 2020 , 6:00 p.m. ET
Operator
For further details see:
Bio-Rad Laboratories Inc (BIO) Q3 2020 Earnings Call TranscriptImage source: The Motley Fool.
Bio-Rad Laboratories Inc (NYSE: BIO)
Q3 2020 Earnings Call
Oct 29, 2020 , 6:00 p.m. ET
Operator
For further details see:
Bio-Rad Laboratories Inc (BIO) Q3 2020 Earnings Call TranscriptMarket Wire News is a media platform, the information on this page was provided by Motley Fool via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Bio-Rad Laboratories Inc. Class A Company Name:
BIO Stock Symbol:
Market:
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market. Management will discuss these results in a conf...
- Bio-Rad expects to make equity investment in support of deal - Agreement provides for global exclusivity in transplant monitoring commercialization - Bio-Rad granted subsequent investment option upon FDA clearance IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corporation (...
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Dr. Andrew Last, Executive Vice President and Chief Operating Officer, is planning to retire by early September of 2024. Dr. Last will remain part of ...